The role of hyperthermic intraperitoneal chemotherapy in newly diagnosed and recurrent ovarian cancer: A time-to-event meta-analysis of randomized trials.

Altayf A, Nelson G, Chiva LM, Restaino S, Fadeli L, Nounou MV, Abuasaker H, Elgazzar M, Shoulkamy T, Elhadi M

Open source

DOI
10.1016/j.ygyno.2026.03.002
Published
2026 May
Container
Gynecologic oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ygyno.2026.03.002,
  title = {The role of hyperthermic intraperitoneal chemotherapy in newly diagnosed and recurrent ovarian cancer: A time-to-event meta-analysis of randomized trials.},
  author = {Altayf A and Nelson G and Chiva LM and Restaino S and Fadeli L and Nounou MV and Abuasaker H and Elgazzar M and Shoulkamy T and Elhadi M},
  year = {2026},
  journal = {Gynecologic oncology},
  doi = {10.1016/j.ygyno.2026.03.002},
  url = {https://doi.org/10.1016/j.ygyno.2026.03.002}
}

RIS

TY  - JOUR
TI  - The role of hyperthermic intraperitoneal chemotherapy in newly diagnosed and recurrent ovarian cancer: A time-to-event meta-analysis of randomized trials.
AU  - Altayf A
AU  - Nelson G
AU  - Chiva LM
AU  - Restaino S
AU  - Fadeli L
AU  - Nounou MV
AU  - Abuasaker H
AU  - Elgazzar M
AU  - Shoulkamy T
AU  - Elhadi M
PY  - 2026
JO  - Gynecologic oncology
DO  - 10.1016/j.ygyno.2026.03.002
UR  - https://doi.org/10.1016/j.ygyno.2026.03.002
ER  - 

APA

A, A., G, N., LM, C., S, R., L, F., MV, N., H, A., M, E., T, S., & M, E. (2026). The role of hyperthermic intraperitoneal chemotherapy in newly diagnosed and recurrent ovarian cancer: A time-to-event meta-analysis of randomized trials.. Gynecologic oncology. https://doi.org/10.1016/j.ygyno.2026.03.002

Source records